Evidence for non-specific effects of live Shingles vaccination against all-cause death and hospitalisation in older adults in England: a population-based cohort study
This population-based cohort study in England provides evidence that live shingles vaccination in adults aged 70 and over is associated with significantly reduced rates of all-cause death, all-cause hospitalization, and infection-related hospitalization, suggesting potential non-specific beneficial effects beyond the vaccine's target disease.